Johnson Anne Nagengast 4
4 · ATAI Life Sciences N.V. · Filed Mar 24, 2025
Insider Transaction Report
Form 4
Johnson Anne Nagengast
Chief Financial Officer
Transactions
- Sale
Common Shares
2025-03-21$1.35/sh−33,545$45,286→ 140,045 total
Footnotes (1)
- [F1]Represents shares sold to satisfy the Reporting Person's tax liability on vesting of restricted stock units.